Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Chugai files for regulatory approval of maxacalcitol

Sep. 10, 1998

New advances in antiobesity drug therapy reported by Novartis

Sep. 10, 1998

Glaxo Wellcome describes hypoglycemic activity of PPAR ligand

Sep. 9, 1998

Novel ACAT inhibitors from DuPont Pharmaceuticals debut at ACS meeting

Sep. 9, 1998

DuPont presents XJ-304 and related compounds as ACAT inhibitors at ACS

Sep. 9, 1998

Pfizer selects GH secretagogue as development candidate

Sep. 8, 1998

Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum

Sep. 8, 1998

Ligand reveals tissue-selective, orally active progestational compound

Sep. 8, 1998

Schering AG describes new progestogenic steroids

Sep. 8, 1998

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

Sep. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...